Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen M Handberg

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Cardiovascular Diagnosis and Therapy|March 21, 2025
Coronary microvascular dysfunction and right ventricular structure and functionAmélie Paquin, Michael D Nelson, Janet Wei, et al.
Journal of Clinical Medicine|February 10, 2019
Multimodal Intervention to Improve Functional Status in Hypertensive Older Adults: A Pilot Randomized Controlled TrialLiliana C Baptista, Byron C Jaeger, Stephen D Anton, et al.
Experimental Gerontology|December 22, 2018
Effect of all-extremity high-intensity interval training vs. moderate-intensity continuous training on aerobic fitness in middle-aged and older adults with type 2 diabetes: A randomized controlled trialChueh-Lung Hwang, Jisok Lim, Jeung-Ki Yoo, et al.
Heart and Mind (Mumbai, India)|December 30, 2021
Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women's Ischemia Syndrome EvaluationAshley S Emami, C Noel Bairey Merz, Jo-Ann Eastwood, et al.
American Heart Journal|October 11, 2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)Daniel F Pauly, B Delia Johnson, R David Anderson, et al.
Medical Hypotheses|September 4, 2012
A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarctionDomenico G Della Rocca, Bradley J Willenberg, Leonardo F Ferreira, et al.
Plos One|February 17, 2017
Acetylcholine versus cold pressor testing for evaluation of coronary endothelial functionAhmed AlBadri, Janet Wei, Puja K Mehta, et al.
The American Journal of Cardiology|November 4, 2020
Preparticipation Cardiac Evaluation Findings in a Cohort of Collegiate Female AthletesCecil A Rambarat, Fred Reifsteck, James R Clugston, et al.
American Heart Journal|February 26, 2025
Rationale and design of the women's ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF)Tatsunori Takahashi, Janet Wei, Ana C Iribarren, et al.
Archives of Internal Medicine|May 13, 2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart ProjectMartha Gulati, Rhonda M Cooper-DeHoff, Candace McClure, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Cardiovascular Diagnosis and Therapy|March 21, 2025
Coronary microvascular dysfunction and right ventricular structure and functionAmélie Paquin, Michael D Nelson, Janet Wei, et al.
Journal of Clinical Medicine|February 10, 2019
Multimodal Intervention to Improve Functional Status in Hypertensive Older Adults: A Pilot Randomized Controlled TrialLiliana C Baptista, Byron C Jaeger, Stephen D Anton, et al.
Experimental Gerontology|December 22, 2018
Effect of all-extremity high-intensity interval training vs. moderate-intensity continuous training on aerobic fitness in middle-aged and older adults with type 2 diabetes: A randomized controlled trialChueh-Lung Hwang, Jisok Lim, Jeung-Ki Yoo, et al.
Heart and Mind (Mumbai, India)|December 30, 2021
Somatic Versus Cognitive Depressive Symptoms as Predictors of Coronary Artery Disease among Women with Suspected Ischemia: The Women's Ischemia Syndrome EvaluationAshley S Emami, C Noel Bairey Merz, Jo-Ann Eastwood, et al.
American Heart Journal|October 11, 2011
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE)Daniel F Pauly, B Delia Johnson, R David Anderson, et al.
Medical Hypotheses|September 4, 2012
A degradable, bioactive, gelatinized alginate hydrogel to improve stem cell/growth factor delivery and facilitate healing after myocardial infarctionDomenico G Della Rocca, Bradley J Willenberg, Leonardo F Ferreira, et al.
Plos One|February 17, 2017
Acetylcholine versus cold pressor testing for evaluation of coronary endothelial functionAhmed AlBadri, Janet Wei, Puja K Mehta, et al.
The American Journal of Cardiology|November 4, 2020
Preparticipation Cardiac Evaluation Findings in a Cohort of Collegiate Female AthletesCecil A Rambarat, Fred Reifsteck, James R Clugston, et al.
American Heart Journal|February 26, 2025
Rationale and design of the women's ischemia syndrome evaluation mechanisms of coronary microvascular dysfunction leading to preheart failure with preserved ejection fraction (WISE Pre-HFPEF)Tatsunori Takahashi, Janet Wei, Ana C Iribarren, et al.
Archives of Internal Medicine|May 13, 2009
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart ProjectMartha Gulati, Rhonda M Cooper-DeHoff, Candace McClure, et al.
Pageof 11